Evaluating new biomarkers for chronic heart failure
Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
This study tests new blood markers to see if they can help improve care and outcomes for people with chronic heart failure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta, Elgharbia) |
| Trial ID | NCT03772275 on ClinicalTrials.gov |
What this trial studies
This study evaluates the clinical and economic value of novel biomarkers in patients with chronic heart failure. It focuses on individuals classified under New York Heart Association (NYHA) Class II-IV. The goal is to determine how these biomarkers can improve patient management and outcomes in heart failure. The study will involve assessing the effectiveness and cost-effectiveness of these biomarkers in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with chronic heart failure classified as NYHA Class II-IV.
Not a fit: Patients with liver or renal dysfunction or diabetes mellitus may not receive benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management strategies for patients with chronic heart failure.
How similar studies have performed: Other studies have explored biomarkers in heart failure, showing promising results, but this specific approach may be novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * NYHA-Class II-IV Exclusion Criteria: * Liver or renal dysfunction. --DM
Where this trial is running
Tanta, Elgharbia
- Sherief Abd-Elsalam — Tanta, Elgharbia, Egypt (Recruiting)
Study contacts
- Principal investigator: Osama M Ibrahim, Prof — Prof of Clinical Pharmacy
- Study coordinator: Sherief Abd-Elsalam, Ph D
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.